Amiodarone

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Amiodarone and local guidelines before prescribing.

Class III antiarrhythmic

Mechanism

Class III antiarrhythmic prolonging repolarisation; also blocks sodium and calcium channels and beta receptors.

Uses

VT/VF, AF and flutter rhythm control, supraventricular tachycardias.

Dosing

Quick reference (Makindo topics site)

Main useAdult doseKey pearl / caution
VT / VF300 mg IV in arrest; 150 mg over 10 min for stable VTMonitor QT, BP, bradycardia.

Source: Makindo topics, Emergency Drugs Collection (topic 1479). Editorial draft, not clinically signed off; doses are as written there. Check BNF and local policy before prescribing.

4 more dose entries from the chapters

Side effects

Thyroid dysfunction, pulmonary fibrosis, hepatitis, photosensitivity, corneal deposits, bradycardia, QT prolongation, neuropathy.

Interactions

Raises levels of digoxin, warfarin and simvastatin; avoid other QT-prolonging drugs; additive bradycardia with beta-blockers and verapamil.

Contraindications and cautions

Thyroid dysfunction, iodine hypersensitivity, bradycardia, heart block, QT prolongation

Monitoring

Baseline and 6-monthly TFT and LFT, annual CXR and eyes if symptoms, ECG

Pregnancy and breastfeeding

Avoid unless essential (neonatal thyroid effects)

Renal and hepatic impairment

No adjustment

Overdose and reversal

Supportive; very long half-life

Special advice

Baseline then regular TFT, LFT, chest X-ray, ECG; sun protection; central IV line for infusions; very long half-life.

More from the textbook: uses, cautions and other points
Where it is discussed in the book